Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster
1 Infection Control and Antimicrobial Stewardship Unit, University Hospital Würzburg, Würzburg, Germany; Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany.
2 Infection Control and Antimicrobial Stewardship Unit, University Hospital Würzburg, Würzburg, Germany.
3 Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK; University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
4 Institute for Hygiene and Microbiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany; Leibniz Institute for Natural Product Research and Infection Biology-Hans-Knoell-Institute, Jena, Germany.
5 Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany.
6 Infection Control and Antimicrobial Stewardship Unit, University Hospital Würzburg, Würzburg, Germany; Institute for Hygiene and Microbiology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany. Electronic address: krone_m@ukw.de.